| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/06/2003 | US20030026792 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 02/06/2003 | US20030026791 Aids therapy; insertion into cell a virus vector |
| 02/06/2003 | US20030026789 Anticancer agents |
| 02/06/2003 | US20030026784 Cardiovascular disorders; genetic engineered mouse |
| 02/06/2003 | US20030026783 Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal transgenesis and in functional inactivation of an endogenous proteins |
| 02/06/2003 | CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs) |
| 02/06/2003 | CA2455681A1 An inducer of apoptosis |
| 02/06/2003 | CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 02/06/2003 | CA2454791A1 Antisense modulation of c-reactive protein expression |
| 02/06/2003 | CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | CA2454183A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 02/06/2003 | CA2453894A1 Antisense modulation of hormone-sensitive lipase expression |
| 02/06/2003 | CA2453653A1 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 02/06/2003 | CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 02/05/2003 | EP1281765A1 Antisense type gene trap vector |
| 02/05/2003 | EP1281763A2 Early growth response-1 (EGR-1) transcription factor |
| 02/05/2003 | EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 02/05/2003 | EP1281758A2 Four human zinc-finger-containing proteins : MDZ3, MDZ4, MDZ7 and MDZ12 |
| 02/05/2003 | EP1281756A1 Regulator of calcineurin |
| 02/05/2003 | EP1281717A2 Putative ion channel |
| 02/05/2003 | EP1280929A2 Vectors for ocular transduction and use thereof for genetic therapy |
| 02/05/2003 | EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 02/05/2003 | EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy |
| 02/05/2003 | EP1280909A2 Human lipocalin homologs and polynucleotides encoding the same |
| 02/05/2003 | EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 02/05/2003 | EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 02/05/2003 | EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 02/05/2003 | EP1280905A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene carboxy terminal peptides |
| 02/05/2003 | EP1280903A2 Ph domain-interacting protein |
| 02/05/2003 | EP1280900A2 Dendritic cell co-stimulatory molecules |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280898A1 Modified es cells and es cell-specific gene |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280827A1 Agonists/antagonists of the gpr56 receptor as appetite control agents |
| 02/05/2003 | EP1280815A1 29 human secreted proteins |
| 02/05/2003 | EP1280572A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280570A2 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280569A1 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280568A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280560A1 Cationic polymer-nucleic acid complexes and methods of making them |
| 02/05/2003 | EP1280549A2 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
| 02/05/2003 | EP1280519A1 Microprojectile delivery system and particulate product |
| 02/05/2003 | EP1280516A1 Method for transdermal or intradermal delivery of molecules |
| 02/05/2003 | EP1280512A2 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280409A1 A gene therapy system and method using alpha-msh and its derivatives |
| 02/05/2003 | EP0932391B1 Fusogenic liposome composition and method |
| 02/05/2003 | EP0871463B1 Regulation of eating behavior |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395580A Human cystine knot polypeptide |
| 02/05/2003 | CN1394874A Human thio-oxidizing proteinoid gene and three-D space structure of its coded protein and physiologic function |
| 02/05/2003 | CN1394872A Gene clone of host cell proteinoid and biological function of its protein |
| 02/05/2003 | CN1394602A Benzoic acid substituted benzopyran fro curing atheroscleorsis |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/04/2003 | USRE37978 Myocardial grafts and cellular compositions |
| 02/04/2003 | US6515199 Gene transfer in poultry by introduction of embryo cells in ovo |
| 02/04/2003 | US6514947 Formulated nucleic acid compositions and methods of administering the same for gene therapy |
| 02/04/2003 | US6514943 Method and composition for preserving viruses |
| 02/04/2003 | US6514939 Mutants of atrial natriuretic factor that are protective for stroke |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514756 Human myoblast cell lines and their uses |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514724 Isolated polynucleotide encoding a polypeptide which has high binding affinity. |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514697 Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections |
| 02/04/2003 | US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer |
| 02/04/2003 | US6514695 Compositions and methods for intraductal gene therapy |
| 02/04/2003 | US6514694 Detecting parasite oocysts in feces by contacting feces sample with a solid support capable of binding oocysts, dryin, washing, adding elution solution and eluting DNA from sample by heating, PCR amplification with primers |
| 02/04/2003 | US6514493 Amino acid sequence encoding an amino-terminal protein fragment of murine glycoprotein 110 |
| 02/04/2003 | CA2271478C Tissue specific expression of retinoblastoma protein |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 02/03/2003 | CA2391627A1 Ribosome structure and protein synthesis inhibitors |
| 01/31/2003 | WO2002012338A2 Screening method |
| 01/31/2003 | CA2417972A1 Screening method |
| 01/30/2003 | WO2003008640A2 Asthma-associated gene |
| 01/30/2003 | WO2003008599A2 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 01/30/2003 | WO2003008598A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | WO2003008595A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/30/2003 | WO2003008586A2 Engineering oncolytic viruses |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008576A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008566A1 Production of radial glial cells |
| 01/30/2003 | WO2003008555A2 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 01/30/2003 | WO2003008554A2 Methods and compositions for cell therapy |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008446A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2002089817A3 Anti-virus agent |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002055656A3 GENE THERAPY USING TGF-$g(b) |